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ABSTRACT
First described by Rokitansky in 1842, and further characterized by Virchow in 1854, amyloidosis is a disorder caused by 
amyloid deposition, a fibrillary insoluble protein. The clinical spectrum of amyloidosis is broad, as the amyloid deposition 
may virtually occur in all tissues. Herein, we report the case of a 66-year-old man with a long-lasting emaciating 
disease, diagnosed, at autopsy, with primary systemic amyloidosis. Amyloid protein deposition was found in many 
tissues and organs. The involvement of the vessels’ wall rendered ischemic injury most prominent in the intestinal loops 
causing mesenteric ischemia. Despite the thorough organic involvement, the immediate cause of death was aspiration 
bronchopneumonia. Massive amyloid deposition was found in virtually all major organs, such as the heart, liver, kidneys, 
spleen, pancreas, adrenals, prostate, skin, and thyroid: the latter, a complication of the amyloidosis known as amyloid 
goiter. Post-mortem review of the deceased’s laboratory workup showed a slightly abnormal kappa:lambda ratio in the 
blood; however, no clonal lymphoplasmacytic disorder was confirmed in the bone marrow and other lymphoreticular 
system organs either by the microscopic examination and immunohistochemical staining. Laser-capture microdissection 
and tandem mass spectrometry of the splenic tissue detected a peptide profile consistent with an immunoglobulin Kappa 
light chain. The presence of amyloid purpura favors the diagnosis of primary systemic amyloidosis. 
Keywords 
Amyloidosis; Multiple Organ Failure; Pneumatosis Cystoides Intestinalis; Tandem Mass Spectrometry; Diagnosis; 
Autopsy.
INTRODUCTION
In 1842, Karl von Rokitansky (1804-1878) 
described the gross appearance of the “waxy or 
lardaceous aspect of the viscera”, which was further 
better characterized as “amorphous and hyaline 
deposits” by Rudolph Virchow (1821-1902) in 1854 
with the aid of the light microscopy. He preferred the 
word “amyloid” to the commonly used terms “waxy” 
or “lardaceous” changes because of the peculiar 
reaction with iodine.
Currently, 36 types of fibrillar proteins that form 
amyloid deposits are described, which generate small 
fibers that clump together in an identical and insoluble 
physical structure. Regardless of the clinical situation 
or chemical composition, once deposited, there is 
no metabolic pathway for their removal, and as the 
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organism is unable to eliminate them, they gradually 
deposit and damage organs and systems.1-4
The amyloidosis can be hereditary or acquired in 
etiology and systemic or localized in distribution. The 
localized form is usually associated with the deposition 
of immunoglobulin light chain (AL type), although 
serum amyloid A protein and transthyretin have been 
reported as causing localized disease, and it commonly 
involves the laryngo-tracheobronchial tree, urogenital 
tract, and skin.5
S y s t em i c  amy lo idos i s  r e su l t s  f r om the 
accumulation of amyloid in a wide range of tissues 
and organs. The primary systemic amyloidosis occurs 
in association with the so-called plasma cell dyscrasias, 
a monoclonal proliferation of plasma cells that 
produce a clonal immunoglobulin protein, i.e., 
monoclonal gammopathies or multiple myeloma, as 
well as other malignant B-cell lymphoproliferative 
disorders with paraproteinemia, i.e., Waldenström’s 
macroglobulinemia. The secondary form of systemic 
amyloidosis occurs in the presence of preceding 
or coexisting chronic inflammatory or infectious 
conditions. It is now well understood why different 
serum amyloidogenic proteins may transform 
into amyloid fibrils with anti-parallel beta-sheet 
conformation that accumulate in different sites and 
cause the disease.6-9
The clinical spectrum of amyloidosis is broad 
as the amyloid deposits may involve virtually all 
organs in different degrees. In the heart, the amyloid 
deposits in the myocardium and causes restrictive 
cardiomyopathy. In the liver, the massive amyloid 
deposition in the portal tracts and sinusoids may 
be associated with hepatic dysfunction and portal 
hypertension. In the kidneys, the glomerular amyloid 
deposition initially causes asymptomatic proteinuria, 
but, as the disease progresses, the renal failure ensues. 
In the gastrointestinal tract, the clinical manifestations 
vary and include abdominal pain, malabsorption, 
and bleeding. Nonspecific symptoms, such as weight 
loss, are also present in the systemic form.10-15 The 
differential diagnosis of systemic amyloidosis is wide 
and depends on the presenting clinical features, which 
can be hepatosplenomegaly, heart failure, hepatic 
dysfunction or altered hepatic enzymes, urinalysis 
alterations with or without renal dysfunction, and skin 
alterations.16
Although it does not define the type of protein 
deposited, the Congo red stain is still the method 
for making the diagnosis of amyloidosis on tissue 
specimens. However, defining the type of amyloidosis is 
crucial as the current treatment of systemic amyloidosis 
directly depends on the molecular type of the amyloid 
protein. The proper diagnosis demands the correlation 
between signs and symptoms, familial history, genetic 
workup, histology, immunohistochemistry, Western 
blot, and proteomics techniques. Currently, mass 
spectrometry (proteomic) is referred to as a powerful 
new diagnostic technique for amyloidosis capable of 
defining which protein is deposited, which can be 
performed on the same material of the biopsy used 
for the tissue demonstration of amyloidosis.17,18
CASE REPORT
A 66-year-old black male was admitted complaining 
of an unexplained weight loss of 30 kg, front neck 
lump, purpuric lesions over the trunk and limbs, and 
proximal weakness over the past year. The laboratory 
workup was consistent with hepatic dysfunction 
with mild elevation of the hepatic enzymes, renal 
failure (creatinine clearance of 40 mL/min) with mild 
proteinuria, normocytic and normochromic anemia, 
and thrombocytopenia. Serum protein electrophoresis 
showed hypoalbuminemia and no abnormality in 
the gamma-globulin zone. The thyroid function was 
normal. Serologic testing for HIV and syphilis were 
negative. The rheumatoid factor and antinuclear 
antibody were within normal limits. The initial working 
diagnosis was systemic vasculitis, and the patient was 
empirically prescribed prednisone without clinical 
response. After two weeks of hospitalization, the 
patient started with intermittent abdominal pain and 
hemodynamic instability. He was transferred to the 
intensive care unit (ICU) due to severe hypotension. 
Unfortunately, the outcome was unfavorable, and he 
died after five days, despite the advanced cardiac and 
respiratory life support. An autopsy was performed 
with the consent of the family.
AUTOPSY FINDINGS
The corpse weighed 65 kg, and the height 
was 1,75 m (BMI of 21.2 kg/m2). On the external 
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examination, the corpse was emaciated. A thyroid 
goiter and several purpuric lesions in the neck, 
trunk, and proximal extremity of both arms were 
easily observed. The skin was friable, so much so 
that a sizeable hematic crust in the sternal region 
was attributed to the cardiac resuscitation maneuver 
(Figure 1).
Microscopic sections of the skin showed massive 
amyloid deposition in the papillary dermis and around 
blood vessels, secondary atrophy of the epidermis, 
and extravasation of red blood cells, which causes the 
purpuric aspect of the clinical lesion and explains the 
friability of the skin (Figure 2).
The thyroid was diffusely enlarged and weighted 
40 g (mean reference range [mRR]; 17 g) (Figure 3A). 
At the cut-surface, the parenchyma was firm and had 
a pale lardaceous appearance. No nodules were found. 
Microscopic sections of the gland showed diffuse 
interstitial amyloid deposition with secondary atrophy 
of the follicles (Figure 3B, C). After Congo red staining, 
the interstitial deposits had apple-green birefringence 
under polarized light (Figure 3D).
At the opening of the thoracic cavity, a mild 
bilateral pleural effusion was drained. The heart 
weight was 450 g (mRR; 325 g), and concentric left 
ventricular hypertrophy was present (Figure 4A). 
The left ventricular wall measured 2.4 cm, the 
septum measured 2.0 cm (mRR, 1.15, and 1.35 cm, 
respectively), and subendocardial whitish areas were 
noted. Coronaries exhibited calcified atherosclerosis 
without critical stenosis, and the valves were normal. At 
the histological examination, amyloid was deposited in 
the blood vessels and intermingling the myocardiocytes 
accompanied by myocardial sclerosis (Figure 4B, C). 
The epicardial fat tissue exhibited amyloid deposition 
in a pattern of amyloid rings (Figure 4D).
At the opening of the trachea, a green-brownish 
fluid resembling enteric-stasis fluid was present. The 
lungs combined weight was 1638 g (mRR; 825 g). 
Their cut surface had bilateral basal congestion, and 
the airways were filled with dark brown secretion. 
The histological examination confirmed the presence 
of bilateral aspiration bronchopneumonia and diffuse 
alveolar damage with hyaline membranes.
Figure 1. External view of the corpse. A – Purpuric cutaneous lesions scattered on the chest and neck – “amyloid 
purpura”; B – Exulcerated lesion in the chest due to the skin friability.
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At the opening of the abdominal cavity, mild 
ascites was collected in the pouch of Douglas, while 
the peritoneal surface and the mesentery fat tissue 
were grossly normal. The liver was enlarged, weighed 
1582 g (mRR; 1430 g), and the external surface was 
smooth and shiny with subcapsular hemorrhagic spots 
(Figure 5A). The consistency was soft and friable. The 
cut surface showed a pale subcapsular area in the right 
Figure 2. Photomicrographs of the skin. A – The epidermis is atrophic, and the dermis shows extensive amyloid 
deposits around the blood vessels, pilosebaceous units, and in the papillary dermis (H&E, 100x); B – High magnification 
view shows vascular damage and extravasation of red blood cells (H&E, 400x).
Figure 3. A – Gross examination of the thyroid: diffuse enlargement of the gland; B, C, and D – Photomicrographs 
of the thyroid: extensive amorphous hyaline material deposition in the interstitium causing marked follicular atrophy. 
The Congo red staining was strongly positive (B - H&E, 20x; C - H&E, 200x; and D - Congo red under polarized light, 
100x).
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Figure 4. A – Gross examination of the heart: cardiomegaly with left ventricular hypertrophy; B, C, and 
D – Photomicrographs of the heart: amyloid deposits are seen in the interstitium between myocardial fibers, and in 
the epicardium around the adipocytes, known as “amyloid rings” pattern (B - H&E, 40x; C - H&E, 40x; and D - H&E, 
100x).
lobe and scattered yellowish focal lesions throughout 
the organ. On microscopy, amyloid deposits were 
conspicuously found in the sinusoids and the portal 
tracts, mainly in the wall of arterioles (Figure 5B, C, D).
The kidneys weighed 224g (mRR; 313g). On the 
external view, they appeared shrunken with a coarse 
and bilaterally granular external surface (Figure 6A). 
On histology, about 30% of the glomeruli were 
globally sclerosed, and the distribution of amyloid was 
heterogeneous. The cortical surface had wedge-shaped 
areas of diffuse glomerular and arteriolar amyloid 
deposition, interstitial fibrosis, atrophic tubules, and 
chronic inflammatory infiltrates, interchanged with 
areas of better-preserved parenchyma with fewer 
amyloid deposits, giving rise to the irregularity of the 
gross external view (Figure 6B). Amyloid deposits were 
also found in the interstitium of the renal medulla 
(Figure 6C) and almost all non-ischemic glomeruli 
(Figure 6D).
Regarding the alimentary tract, a diffuse dilatation 
of the stomach and bowels with scattered dark-
green colored intestinal segments, emphysematous 
enteritis (pneumatosis intestinalis), and diffuse loss of 
the mucosal folds were observed (Figure 7A and 7B). 
Histologically, there was coagulative ischemic necrosis 
of the mucosa (Figure 7C). A large amount of amyloid 
protein deposits was found in the mesenteric and 
intestinal blood vessel walls (Figure 7D), which may 
have hampered the bowels’ perfusion and caused the 
ischemic findings.
The h is to log ic  examinat ion of  the bone 
marrow showed hypocellularity and interstitial and 
perivascular amyloid deposits (Figure 8A), without 
morphological signs of myeloproliferative disorder. 
Immunohistochemical staining for CD3, CD20, 
CD138, Kappa, and Lambda were inconclusive. 
Massive amyloid deposition was also found in 
the enlarged spleen (weight= 198 g [RR 112 g]) 
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(Figure 8B), the adrenals (Figure 8B), the tongue 
(Figure 8C), the prostate (Figure 9A), and the 
pancreas (F igure 9B).  Gross and microscopic 
examinations of the central nervous system were 
unremarkable.
A sample of splenic tissue was subjected to 
8-micron sections and Congo red staining. The 
positive regions of the tissue were dissected by laser 
microdissection microscopy and processed by peptide 
extraction. The obtained peptide extracts were 
then analyzed by liquid chromatography coupled to 
ultra-resolution tandem mass spectrometry. Mass 
spectrometry detected a peptide profile consistent 
with an immunoglobulin Kappa light chain, confirming 
the diagnosis of systemic AL (kappa light chain) 
amyloidosis.
DISCUSSION
In our case, the definitive diagnosis of amyloid 
light-chain (AL) systemic amyloidosis was made 
through laser-capture microdissection and tandem 
mass spectrometry of a splenic tissue sample. Although 
the immunohistochemical panel performed on the 
bone marrow sample was inconclusive – likely due 
to post mortem artifacts – the diagnosis of primary 
amyloidosis was plausible since no clue of any other 
disease was found in the autopsy.
Amyloid deposits disrupt tissue structure leading 
to organ failure. Symptoms depend on the specific 
or major distribution of amyloid and, consequently, 
the organ impairment.16 In our case, diffuse amyloid 
deposition was found in the heart, liver, kidneys, spleen, 
Figure 5. A – Gross view of the liver. Note the hepatic enlargement with hemorrhagic spots and yellowish necrotic 
foci; B, C, and D – Photomicrographs of the liver; B – shows diffuse portal tract, periportal tract, and sinusoidal 
amyloid deposition (H&E, 40x); C – viable hepatic parenchyma on the left and geographic hemorrhagic hepatic 
necrosis on the right side (H&E, 40x); D – High magnification of the portal tract showing the arteriolar wall thickening 
by amyloid deposits (H&E, 100x).
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prostate, thyroid gland, adrenals, and bone marrow. 
This extensive organic infiltration by the amyloid 
protein was the cause of the “in vivo” unexplained 
weight loss, purpura, liver failure, progressive renal 
insufficiency, and pancytopenia. Clinically, the patient 
also presented severe abdominal pain attributed 
to acute intestinal ischemia secondary to massive 
amyloid deposition in the intestinal blood vessels 
walls. Pneumatosis intestinalis has been previously 
described as a rare manifestation of gastrointestinal 
amyloidosis.19-23 Intestinal ischemia causes bowel 
dilation, aperistalsis, and bacterial translocation what 
explains the septic shock, unconsciousness or mental 
obnubilation, and consequent aspiration pneumonia. 
The sequence of these events explains the patient’s 
cause of death.
Weight loss is a frequent symptom of the systemic 
form of the disease, and it is likely multifactorial. Patients 
with systemic amyloidosis often present gastrointestinal 
involvement that may explain altered intestinal habits, 
lack of appetite, and latent hemorrhages due to direct 
mucous membrane impairment, aggression to the 
integrity of blood vessels, and changes of neuropathic 
nature.24 Secondary protein-losing enteropathy, 
associated with refractory nausea and vomiting, has 
been described in some patients and can lead to severe 
hypoalbuminemia.25 A complete clinical history of the 
patient was unavailable. However, as the emaciation 
was remarkable, we hypothesize that a chronic 
insufficient vascular supply to the gastrointestinal tract 
was the underlying cause of the patient’s emaciation.
The involvement of the skin is more frequent 
in patients with primary systemic amyloidosis.26 
Manifestations may vary from periorbital pinch purpura 
associated with minor trauma, a conspicuous sign 
named “racoon eyes”, to scattered or diffuse purpuric 
Figure 6. A – Gross view of the formalin-fixed kidneys, after the capsule detachment, showing coarse retractions 
throughout the cortical surface of both kidneys, causing volumetric retraction. B, C, and D – Photomicrographs of 
the kidney; B – Microscopic representation of the atrophic cortex due to amyloid deposition in the glomeruli and 
vessels (H&E, 50x); C and D – Conspicuous amyloid deposits in the tubular interstitium, glomerular mesangium and 
the arteriolar walls (C - H&E, 40X; and D - H&E, 400X).
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rash (petechiae and ecchymosis), as seen in our case.27 
Two main factors which seem to play a role in the 
development of these lesions are: clotting alterations, 
namely a decrease in circulating coagulation factors 
and an increase in fibrinolysis; and subendothelial 
amyloid deposits in the blood vessels of the skin, 
favoring rupture and extravasation of red blood cells 
to the dermis.28
Thyroid goiter is one of the complications of 
systemic amyloidosis previously described in the 
literature and highlighted in this case. The gross 
examination shows the organ enlargement, and the 
cut surface is typically pale, firm, and has a waxy (or 
lardaceous) appearance. Histologically, the amyloid 
protein deposits are found in the interstitium, causing 
compression and secondary atrophy of the thyroid 
follicles.29-32 One of the lessons learned with this 
case is that the presence of thyroid goiter may favor 
the diagnosis of systemic amyloidosis over systemic 
vasculitis. Fast-growing goiter has been previously 
described as the first clinical manifestation of systemic 
amyloidosis in one patient.33
“Amyloid rings” is the amyloid deposits pattern 
in the adipose tissue (filling the intercellular space 
between the adipocytes). This finding was present, 
in our case, in the skin hypodermis, epicardium, 
tongue, and gastrointestinal tract subserosal fat. 
The pathologist should be aware of looking for 
this specific finding when examining a specimen 
from a periumbil ical fat biopsy performed to 
investigate systemic amyloidosis. In clinical practice, 
the biopsy of subcutaneous fatty tissue (sensitivity 
around 75% and specificity around 90%) is usually 
preferred over trans-dermal core kidney biopsy 
(sensitivity close to 100%) due to being a lower 
risk procedure.34-39
Figure 7. A - Gross view of the cecum with dark-green ischemic and necrotic mucosa; B – Gross view of a small 
bowel segment showing pneumatosis intestinalis; C and D – Photomicrographs of the small intestine wall and the 
mesentery. Note the coagulative necrosis of the enteric mucosa (C – H&E, 100x) and the amyloid deposits in the 
mesenteric blood vessels (D - Congo red under polarized light, 400x).
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Figure 8. Photomicrographs of the bone marrow (A - H&E, 200x); the spleen (B - H&E, 10x); the adrenal (C - H&E, 
50x) and the tongue adipose tissue (D - H&E, 100x). Note the hypocellular bone marrow with amyloid deposits in 
blood vessels and the interstitium; the micronodular aspect of the perifollicular amyloid deposition in the spleen; 
the interstitial deposits in the adrenal; and the diffuse “amyloid rings” pattern seen around the adipocytes in the 
tongue.
Figure 9. Photomicrographs of the prostate (A - H&E, 50x) and pancreas (B - H&E, 50x), showing amyloid deposits 
in the interstitium and blood vessels walls.
CONCLUSION
Despite the coexistence of a rich clinical feature 
and the availability of a diagnostic method, systemic 
amyloidosis remains misdiagnosed or undiagnosed. 
The unfamiliarity of the clinicians with this disease 
may explain the lack of early diagnosis. Widespread 
skin vascular lesions accompanied by polyvisceral 
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involvement should always raise the hypothesis of 
systemic amyloidosis. Other manifestations of the 
disease include thyroid goiter, hepatosplenomegaly, 
and even pneumatosis intestinalis. In this case, a post-
mortem examination was essential to clarify the cause 
of death, and therefore a precise death certificate. 
Additionally, the autopsy offered information better 
to understand the patient’s symptoms and laboratory 
findings. THINK ABOUT AMYLOIDOSIS!
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